2017. ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer. Biomedical Research and Therapy. 4, S (Sep. 2017), S33. DOI:https://doi.org/10.15419/bmrat.v4iS.243.